 HomeProductsKey IntermediatesPertuzumab CAS 380610-27-5 2C4 breast cancer.

Contact Supplier

Ms. Caroline

Leave a message

Contact Now

You May Like

Nootropics Powder Phenibut for Fatigue Reduce CAS 1078-21-3 Contact Now

4-Amino-3-Phenylbutanoic Acid Phenibut CAS 1078-21-3 Contact Now

Pharmaceutical Grade Lysozyme Powder CAS 12650-88-3 Contact Now

CAS 302962-49-8 Dasatinib for Anti-Cancer Contact Now

First Class Gestonorone Acetate Trimegestone CAS 2137-18-0 Contact Now

Medroxyprogesterone Acetate MPA Powder CAS: 71-58-9 Contact Now

99% Purity Megestrol Powder CAS: 3562-63-8 Contact Now

17a-Hydroxyprogesterone Caproate 630-56-8 OHPC Powder Contact Now

 

Pertuzumab CAS 380610-27-5 2C4 breast cancer.

Name: cb-03-01
Uploaded: 2022-12-18T13:04:20+08:00
Description: Pertuzumab (also known as 2C4, trade name Perjeta) is a monoclonal antibody.It was the first monoclonal

$20 - 30 /Gram

10 /Gram (Min. Order)

option:

10 grams per vial/bag

Payment Type:

T/T,Paypal

Incoterm:

FOB

Min. Order:

10 Gram

Transportation:

Land,Air,Express,Ocean

Port:

Shanghai,Shenzhen,Guangzhou

Contact Now

 Chat Now

Product Description

Product Attributes
Supply Ability & Additional Information
Packaging & Delivery

< >

Overview

Product Attributes

Model No.: 2C4

Brand: Rhine

Grade: Phamaceutical Grade

Place Of Origin: China

Test Method: HPLC UV COA

Cas: 380610-27-5

Molecular Weight: 277.408

Molecular Formula: C17H27NO2

Specification: 10g:vial/bag

Package: Bottles, foil bags

Trademark: RHINE

Supply Ability & Additional Information

Packaging: Foil bag /bottle

Productivity: 500boxes per month

Transportation: Land,Air,Express,Ocean

Place of Origin: china

Supply Ability: 500grams/month

Certificate: N/A

HS Code: 2934993000

Port: Shanghai,Shenzhen,Guangzhou

Payment Type: T/T,Paypal

Incoterm: FOB

Packaging & Delivery

Selling Units:: Gram

Package Type:: Foil bag /bottle

Pertuzumab (also known as 2C4, trade name Perjeta) is a monoclonal antibody.It was the first monoclonal antibody to be called a "HER dimerization inhibitor". By binding to HER2, it blocks heterodimerization of HER2 with other HER receptors, thereby slowing tumor growth.Active Pharmaceutical Ingredients This product is indicated for adjuvant therapy in combination with trastuzumab and chemotherapy in patients with HER2-positive early breast cancer at high risk of recurrence. ...

Product Categories : Key Intermediates

Hot Products

Email to this supplier

*Subject:
*To:

Ms. Caroline
*Email:
*Message:

Your message must be between 20-8000 characters